Role of stereotactic radiosurgery in patients with more than four brain metastases

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

References

• 1  Gavrilovic IT, Posner JB. Brain metastases: epidemiology and pathophysiology. J. Neurooncol.75(1),5–14 (2005).
  MedlineGoogle Scholar
• 2  Posner JB. Management of brain metastases. Rev. Neurol.148(6–7),477–487 (1992).
  Medline CASGoogle Scholar
• 3  Reveiz L, Rueda JR, Cardona AF. Chemotherapy for brain metastases from small-cell lung cancer. Cochrane Database Syst. Rev.13(6),CD007464 (2012).
  Google Scholar
• 4  Margolin K, Ernstoff MS, Hamid O et al. Ipilimumab in patients with melanoma and brain metastases: an open-label, Phase 2 trial. Lancet Oncol.13(5),459–465 (2012).
  Medline CASGoogle Scholar
• 5  Dea N, Borduas M, Kenny B, Fortin D, Mathieu D. Safety and efficacy of Gamma-knife surgery for brain metastases in eloquent locations. J. Neurosurg.113(Suppl.),79–83 (2010).
  MedlineGoogle Scholar
• 6  Elliott RE, Rush S, Morsi A et al. Neurological complications and symptom resolution following Gamma-knife surgery for brain metastases 2 cm or smaller in relation to eloquent cortices. J. Neurosurg.113(Suppl.),53–64 (2010).
  MedlineGoogle Scholar
• 7  Park HS, Yu JB, Knisely JPS, Chang VLS. Outcomes following Gamma-knife for metastases. Gamma-Knife Radiosurg.1,1–26 (2011).
  Google Scholar
• 8  Rauch PJ, Park HS, Knisely JP, Chiang VL, Vortmeyer AO. Delayed radiation-induced vasculitic leukoencephalopathy. Int. J. Radiat. Oncol. Biol. Phys.83(1),369–375 (2012).
  MedlineGoogle Scholar
• 9  DeAngelis LM, Delattre JY, Posner JB. Radiation-induced dementia in patients cured of brain metastases. Neurology39(6),789–796 (1989).
  Medline CASGoogle Scholar
• 10  Tallet AV, Azria D, Barlesi F et al. Neurocognitive function impairment after whole brain radiotherapy for brain metastases: actual assessment. Radiat. Oncol.7,77 (2012).
  MedlineGoogle Scholar
• 11  Raber J, Rola R, Lefevour A et al. Radiation-induced cognitive impairments are associated with changes in indicators of hippocampal neurogenesis. Radiat. Res.162(1),39–47 (2004).
  Medline CASGoogle Scholar
• 12  Gondi V, Hermann BP, Mehta MP, Tome WA. Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors. Int. J. Radiat. Oncol. Biol. Phys.83(4),e487–493 (2012).
  MedlineGoogle Scholar
• 13  Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int. J. Radiat. Oncol. Biol. Phys.45(2),427–434 (1999).
  Medline CASGoogle Scholar
• 14  Andrews DW, Scott CB, Sperduto PW et al. Whole-brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase III results of the RTOG 9508 randomised trial. Lancet363(9422),1665–1672 (2004).▪ Important study, despite its problems, because it provides class I evidence of the benefit of stereotactic radiosurgery (SRS) for patients with one to three brain metastases. A survival advantage was only seen for patients with a single metastasis, but analyses showed better lesion control and less steroid use for patients with two to three brain metastases.
  MedlineGoogle Scholar
• 15  Aoyama H, Shirato H, Tago M et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA295(21),2483–2491 (2006).▪ Class I evidence is provided of equivalent survival and 1year neurocognitive outcomes for patients with one to four brain metastases with either whole-brain radiation therapy (WBRT) and SRS or SRS alone.
  Medline CASGoogle Scholar
• 16  Aoyama H, Tago M, Kato N et al. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int. J. Radiat. Oncol. Biol. Phys.68(5),1388–1395 (2007).▪ Class I evidence is provided of equivalent survival and 1year neurocognitive outcomes for patients with one to four brain metastases with either WBRT and SRS or SRS alone.
  MedlineGoogle Scholar
• 17  Chang EL, Wefel JS, Hess KR et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol.10(11),1037–1044 (2009).▪▪ Neurocognitive outcomes were inferior after 4 months in patients who had WBRT as part of initial management after SRS for one to three brain metastases. Although only the Hopkins Verbal Learning Test-Revised was significantly different, none of the results from other neurocognitive testing instruments favored the group that received WBRT. There is little reason to assume that the neurocognitive harm from WBRT would be substantially different for individuals with more than three brain metastases.
  MedlineGoogle Scholar
• 18  Kocher M, Soffietti R, Abacioglu U et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 2295226001 study. J. Clin. Oncol.29(2),134–141 (2011).
  MedlineGoogle Scholar
• 19  Serizawa T, Iuchi T, Ono J et al. Gamma-knife treatment for multiple metastatic brain tumors compared with whole-brain radiation therapy. J. Neurosurg.93(Suppl. 3),32–36 (2000).
  MedlineGoogle Scholar
• 20  Park SH, Hwang SK, Kang DH et al. Gamma-knife radiosurgery for multiple brain metastases from lung cancer. J. Clin. Neurosci.16(5),626–629 (2009).
  MedlineGoogle Scholar
• 21  Hunter GK, Suh JH, Reuther AM et al. Treatment of five or more brain metastases with stereotactic radiosurgery. Int. J. Radiat. Oncol. Biol. Phys.83(5),1394–1398 (2012).
  MedlineGoogle Scholar
• 22  Chang WS, Kim HY, Chang JW, Park YG, Chang JH. Analysis of radiosurgical results in patients with brain metastases according to the number of brain lesions: is stereotactic radiosurgery effective for multiple brain metastases? J. Neurosurg.113(Suppl.),73–78 (2010).
  MedlineGoogle Scholar
• 23  Raldow AC, Chiang VL, Knisely JP, Yu JB. Survival and intracranial control of patients with 5 or more brain metastases treated with Gamma-knife stereotactic radiosurgery. Am. J. Clin. Oncol.14,14 (2012).
  Google Scholar
• 24  Serizawa T, Hirai T, Nagano O et al. Gamma-knife surgery for 1–10 brain metastases without prophylactic whole-brain radiation therapy: analysis of cases meeting the Japanese prospective multi-institute study (JLGK0901) inclusion criteria. J. Neurooncol.98(2),163–167 (2010).
  MedlineGoogle Scholar
• 25  Suzuki S, Omagari J, Nishio S, Nishiye E, Fukui M. Gamma-knife radiosurgery for simultaneous multiple metastatic brain tumors. J. Neurosurg.3(Suppl. 3),30–31 (2000).
  Google Scholar
• 26  Kim CH, Im YS, Nam DH, Park K, Kim JH, Lee JI. Gamma-knife radiosurgery for ten or more brain metastases. J. Korean Neurosurg. Soc.44(6),358–363 (2008).
  MedlineGoogle Scholar
• 27  Grandhi R, Kondziolka D, Panczykowski D et al. Stereotactic radiosurgery using the Leksell Gamma-knife Perfexion unit in the management of patients with 10 or more brain metastases. J. Neurosurg.25,25 (2012).
  Google Scholar
• 28  Yamamoto M, Ide M, Nishio S, Urakawa Y. Gamma-knife radiosurgery for numerous brain metastases: is this a safe treatment? Int. J. Radiat. Oncol. Biol. Phys.53(5),1279–1283 (2002).
  MedlineGoogle Scholar
• 29  Yang CC, Ting J, Wu X, Markoe A. Dose volume histogram analysis of the Gamma-knife radiosurgery treating twenty-five metastatic intracranial tumors. Stereotact. Funct. Neurosurg.70(Suppl. 1),41–49 (1998).
  MedlineGoogle Scholar
• 30  Yamamoto M, Barfod BE, Urakawa Y. Gamma-knife radiosurgery for brain metastases of non-lung cancer origin: focusing on multiple brain lesions. Prog. Neurol. Surg.22,154–169 (2009).
  MedlineGoogle Scholar
• 31  Yamamoto M, Kawabe T, Barfod BE. How many metastases can be treated with radiosurgery? Prog. Neurol. Surg.25,261–272 (2012).
  MedlineGoogle Scholar
• 32  Nam TK, Lee JI, Jung YJ et al. Gamma-knife surgery for brain metastases in patients harboring four or more lesions: survival and prognostic factors. J. Neurosurg.102(Suppl.),147–150 (2005).
  MedlineGoogle Scholar
• 33  Bhatnagar AK, Flickinger JC, Kondziolka D, Lunsford LD. Stereotactic radiosurgery for four or more intracranial metastases. Int. J. Radiat. Oncol. Biol. Phys.64(3),898–903 (2006).
  MedlineGoogle Scholar
• 34  Gaspar L, Scott C, Rotman M et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int. J. Radiat. Oncol. Biol. Phys.37(4),745–751 (1997).
  Medline CASGoogle Scholar
• 35  Karlsson B, Hanssens P, Wolff R, Soderman M, Lindquist C, Beute G. Thirty years’ experience with Gamma-knife surgery for metastases to the brain. J. Neurosurg.111(3),449–457 (2009).
  MedlineGoogle Scholar
• 36  Serizawa T, Yamamoto M, Nagano O et al. Gamma-knife surgery for metastatic brain tumors. J. Neurosurg.109(Suppl.),118–121 (2008).
  MedlineGoogle Scholar
• 37  Yamamoto M, Sato Y, Serizawa T et al. Subclassification of recursive partitioning analysis class II patients with brain metastases treated radiosurgically. Int. J. Radiat. Oncol. Biol. Phys.83(5),1399–1405 (2012).▪▪ Provides tools to help better predict the survival prognosis of RTOG recursive partitioning analysis class II brain metastasis patients who are primarily managed with SRS.
  MedlineGoogle Scholar
• 38  Serizawa T, Yamamoto M, Sato Y et al. Gamma-knife surgery as sole treatment for multiple brain metastases: 2-center retrospective review of 1508 cases meeting the inclusion criteria of the JLGK0901 multi-institutional prospective study. J. Neurosurg.113(Suppl.),48–52 (2010).
  MedlineGoogle Scholar
• 39  Sperduto PW, Kased N, Roberge D et al. Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J. Clin. Oncol.30(4),419–425 (2012).▪▪ Provides a means to help prognosticate survival outcomes for patients with brain metastases of various histologies and has been used to stratify patients in ongoing and upcoming clinical trials.
  MedlineGoogle Scholar
• 40  Sperduto PW, Kased N, Roberge D et al. Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases. Int. J. Radiat. Oncol. Biol. Phys.82(5),2111–2117 (2012).▪▪ Provides a means to help prognosticate survival outcomes for patients with brain metastases of various histologies and has been used to stratify patients in ongoing and upcoming clinical trials.
  MedlineGoogle Scholar
• 41  Knisely JP, Yamamoto M, Gross CP, Castrucci WA, Jokura H, Chiang VL. Radiosurgery alone for 5 or more brain metastases: expert opinion survey. J. Neurosurg.113(Suppl.),84–89 (2010).
  MedlineGoogle Scholar
• 42  Mehta MP, Tsao MN, Whelan TJ et al. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int. J. Radiat. Oncol. Biol. Phys.63(1),37–46 (2005).
  MedlineGoogle Scholar
• 43  Tsao MN, Lloyd NS, Wong RK. Clinical practice guideline on the optimal radiotherapeutic management of brain metastases. BMC Cancer5,34 (2005).
  MedlineGoogle Scholar
• 101  Radiation Therapy Oncology Group. RTOG 0614 results at ASTRO 2012: memantine shown to have cognition benefit. www.rtog.org/News/tabid/72/articleType/ArticleView/articleId/48/RTOG-0614-Resuts-at-ASTRO-2012-Memantine-Shown-to-Have-Cognition-Benefit.aspx▪ First study to provide class I evidence that an intervention given during WBRT can improve the neurocognitive performance of patients treated with WBRT
  Google Scholar
• 102  Radiation Therapy Oncology Group. A Phase II trial of hippocampal avoidance during whole brain radiotherapy for brain metastases – RTOG CCOP study. www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=0933
  Google Scholar
• 103  North Central Cancer Treatment Group. Stereotactic radiation therapy with or without whole-brain radiation therapy in treating patients with brain metastases. http://clinicaltrials.gov/ct2/show/NCT00377156
  Google Scholar
• 104  World Science. Higuchi Y, Serizawa T, Yamamoto M et al. Prospective multi-institute study of gamma-knife radiosurgery alone treatment for patients with 1–10 brain metastases (JLGK0901): Interim Monitoring Report. www.world-sci.com/read.aspx?id=307
  Google Scholar
• 105  National Comprehensive Cancer Network. NCCN guidelines for CNS cancer. www.nccn.org/professionals/physician_gls/f_guidelines.asp#cns
  Google Scholar
• 106  Cancer Care. Tsao MN, Laetsch NS, Wong RKS, Laperriere N. Supportive Care Guidelines Group and Neuro-Oncology Disease Site Group of Cancer Care Ontario’s Program in evidence-based care. Management of brain metastases: role of radiotherapy alone or in combination with other treatment modalities. Program in evidence-based care practice guideline. www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=34399
  Google Scholar
• 107  North American Gamma-knife Consortium. NAGKC newsletter fall 2012. www.nagkc.com/news/newsletter/2012-05-spring.pdf
  Google Scholar